Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)
Status:
Completed
Trial end date:
2020-12-22
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy and safety of BoNT/A-DP in the treatment of
glabellar lines in comparison with placebo, including efficacy after repeat treatments and
long term safety.
Phase:
Phase 3
Details
Lead Sponsor:
Croma-Pharma GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A